These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20650355)

  • 1. Assessment of the potential heart donor: a role for biomarkers?
    Dronavalli VB; Banner NR; Bonser RS
    J Am Coll Cardiol; 2010 Jul; 56(5):352-61. PubMed ID: 20650355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Induction of left ventricular remodeling and dysfunction in the recipient heart following donor heart myocardial infarction: new insights into the pathological role of tumor necrosis factor-alpha from a novel heterotopic transplant-coronary ligation model].
    Nakamura H; Takata S; Umemoto S; Matsuzaki M
    J Cardiol; 2003 Jan; 41(1):41-2. PubMed ID: 12564114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the donor pool: use of marginal donors for solid organ transplantation.
    Alexander JW; Zola JC
    Clin Transplant; 1996 Feb; 10(1 Pt 1):1-19. PubMed ID: 8652891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the cytokine response in liver donors at the time of organ procurement and association with allograft function after orthotopic transplantation.
    Palombo JD; Burke PA; Moldawer LL; Forse RA; Lewis WD; Jenkins RL
    J Am Coll Surg; 1994 Aug; 179(2):209-19. PubMed ID: 7519108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult orthotopic heart transplantation using undersized pediatric donor hearts. Technique and postoperative management.
    Jeevanandam V; Mather P; Furukawa S; Todd B; Regillo T; Bove AA; McClurken J; Addonizio VP
    Circulation; 1994 Nov; 90(5 Pt 2):II74-7. PubMed ID: 7955288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era.
    Weiss ES; Allen JG; Patel ND; Russell SD; Baumgartner WA; Shah AS; Conte JV
    Circ Heart Fail; 2009 Sep; 2(5):401-8. PubMed ID: 19808369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of patients undergoing transplantation with older donor hearts.
    Drinkwater DC; Laks H; Blitz A; Kobashigawa J; Sabad A; Moriguchi J; Hamilton M
    J Heart Lung Transplant; 1996 Jul; 15(7):684-91. PubMed ID: 8820784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The actual and potential supply of organ donors in the United States.
    Evans RW
    Clin Transpl; 1990; ():329-41. PubMed ID: 2103157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended donor age in cardiac transplantation.
    Schüler S; Warnecke H; Loebe M; Fleck E; Hetzer R
    Circulation; 1989 Nov; 80(5 Pt 2):III133-9. PubMed ID: 2805293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience.
    Wittwer T; Wahlers T
    Transpl Int; 2008 Feb; 21(2):113-25. PubMed ID: 18062790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of a novel solution, Somah, for the procurement and preservation of beating and nonbeating donor hearts for transplantation.
    Thatte HS; Rousou L; Hussaini BE; Lu XG; Treanor PR; Khuri SF
    Circulation; 2009 Oct; 120(17):1704-13. PubMed ID: 19822811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers after heart transplantation: nongenomic.
    Dengler TJ; Gleissner CA; Klingenberg R; Sack FU; Schnabel PA; Katus HA
    Heart Fail Clin; 2007 Jan; 3(1):69-81. PubMed ID: 17545010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Strategies for a greater supply of organs for transplantation].
    Gridelli B; Perico N; Remuzzi G
    Recenti Prog Med; 2001 Jan; 92(1):9-15. PubMed ID: 11260978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended donor criteria for heart transplantation.
    Schüler S; Parnt R; Warnecke H; Matheis G; Hetzer R
    J Heart Transplant; 1988; 7(5):326-30. PubMed ID: 3058900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure.
    Fonarow GC; Horwich TB
    Rev Cardiovasc Med; 2003; 4 Suppl 4():S20-8. PubMed ID: 14564225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are efforts at expanding the donor pool misdirected?
    Rayburn BK; Burton TM; Wannenburg T; Pennington DG; Oaks TE
    J Heart Lung Transplant; 1998 Oct; 17(10):998-1003. PubMed ID: 9811408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the donor pool: use of a donor heart having undergone recent cardiac surgery.
    Drummond-Webb JJ; Schmitz ML; Johnson CE; Frazier EA
    J Heart Lung Transplant; 2004 May; 23(5):639-40. PubMed ID: 15135384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of the potential number of donor organs in 1988 and 1989 in 13 hospitals with a major neurosurgical department].
    Kodde JH; Kerkhoff AH
    Ned Tijdschr Geneeskd; 1992 Apr; 136(17):839-44. PubMed ID: 1522929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selection of donors for heart transplantation].
    Shumakov VI; Moĭsiuk IaG; Dolbin AG; Khubutiia ASh; Kriuchkov AI; Vavilov PA
    Vestn Khir Im I I Grek; 1990 Jul; 145(7):7-12. PubMed ID: 2176403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique.
    Wheeldon DR; Potter CD; Oduro A; Wallwork J; Large SR
    J Heart Lung Transplant; 1995; 14(4):734-42. PubMed ID: 7578183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.